{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T04:14:45Z","timestamp":1742271285710,"version":"3.40.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajicjournal.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ajic.2024.11.005","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T22:27:46Z","timestamp":1731623266000},"page":"514-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Threshold modeling for antibiotic stewardship in Oman"],"prefix":"10.1016","volume":"53","author":[{"given":"Zainab Said","family":"Al-Hashimy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubarak","family":"Al-Yaqoobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal Al","family":"Jabari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawal Al","family":"Kindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Saleh Al","family":"Kazrooni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara R.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feras Darwish","family":"Elhajji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart E.","family":"Bond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Lattyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoon A.","family":"Aldeyab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2024.11.005_bib1","series-title":"Global Pharmaceutical Policy","first-page":"331","article-title":"Global antibiotics use and resistance","author":"Aldeyab","year":"2020"},{"key":"10.1016\/j.ajic.2024.11.005_bib2","first-page":"181","article-title":"The worldwide threat of antimicrobial resistance","volume":"95","author":"Wise","year":"2008","journal-title":"Curr Sci"},{"key":"10.1016\/j.ajic.2024.11.005_bib3","unstructured":"O'neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Review on Antimicrobial Resistance; 2014."},{"key":"10.1016\/j.ajic.2024.11.005_bib4","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/499406","article-title":"The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs","volume":"42","author":"Cosgrove","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2024.11.005_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","article-title":"Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe","volume":"18","author":"Canton","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajic.2024.11.005_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3904\/kjim.2012.27.2.128","article-title":"Current epidemiology and growing resistance of gram-negative pathogens","volume":"27","author":"Livermore","year":"2012","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.ajic.2024.11.005_bib7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1445-5994.2012.02809.x","article-title":"Point-prevalence study of inappropriate antibiotic use at a tertiary Australian hospital","volume":"42","author":"Ingram","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.ajic.2024.11.005_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlab047","article-title":"A multicentre point prevalence survey of patterns and quality of antibiotic prescribing in Indonesian hospitals","volume":"3","author":"Limato","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.ajic.2024.11.005_bib9","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.46.20316-en","article-title":"The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use","volume":"17","author":"Zarb","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ajic.2024.11.005_bib10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajic.2024.11.005_bib11","doi-asserted-by":"crossref","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"Klein","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajic.2024.11.005_bib12","doi-asserted-by":"crossref","first-page":"e893","DOI":"10.1016\/S2542-5196(21)00280-1","article-title":"Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study","volume":"5","author":"Browne","year":"2021","journal-title":"Lancet Planet Health"},{"key":"10.1016\/j.ajic.2024.11.005_bib13","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3390\/antibiotics12121665","article-title":"The outcome of antibiotic overuse before and during the COVID-19 pandemic in a tertiary care hospital in Oman","volume":"12","author":"Pandak","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2024.11.005_bib14","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1073\/pnas.96.3.1152","article-title":"The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance","volume":"96","author":"Austin","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajic.2024.11.005_bib15","first-page":"94","article-title":"Antibiotic consumption and resistance: results of the SPIN-UTI project of the GISIO-SItI","volume":"39","author":"Agodi","year":"2015","journal-title":"Epidemiol Prev"},{"key":"10.1016\/j.ajic.2024.11.005_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-018-0430-1","article-title":"Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014","volume":"7","author":"Yang","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ajic.2024.11.005_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11845-016-1538-z","article-title":"Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005-2014","volume":"186","author":"Stapleton","year":"2017","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.ajic.2024.11.005_bib18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ajic.2024.11.005_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003543.pub3","article-title":"Interventions to improve antibiotic prescribing practices for hospital inpatients","author":"Davey","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajic.2024.11.005_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13756-019-0471-0","article-title":"Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review","volume":"8","author":"Nathwani","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ajic.2024.11.005_bib21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jac\/dkaa464","article-title":"Impact of an antimicrobial stewardship programme on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistant Acinetobacter baumannii (CRAb) in hospitals in Jordan","volume":"76","author":"Yusef","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2024.11.005_bib22","unstructured":"Jirjees F.J., Al-Obaidi H.J., Sartaj M., et al. Antibiotic use and resistance in hospitals: time-series analysis strategy for determining and prioritising interventions; 2020."},{"key":"10.1016\/j.ajic.2024.11.005_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jac\/dkn198","article-title":"Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis","volume":"62","author":"Aldeyab","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2024.11.005_bib24","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1128\/AAC.01214-08","article-title":"Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients","volume":"53","author":"Aldeyab","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2024.11.005_bib25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jac\/dkq525","article-title":"Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community","volume":"66","author":"Vernaz","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2024.11.005_bib26","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41564-019-0410-0","article-title":"A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance","volume":"4","author":"L\u00f3pez-Lozano","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ajic.2024.11.005_bib27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/jac\/dkaa463","article-title":"Identification of thresholds in relationships between specific antibiotic use and carbapenem-resistant Acinetobacter baumannii (CRAb) incidence rates in hospitalized patients in Jordan","volume":"76","author":"Hayajneh","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2024.11.005_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/antibiotics11060775","article-title":"Identifying targets for antibiotic use for the management of carbapenem-resistant Acinetobacter baumannii (CRAb) in hospitals-a multi-centre nonlinear time-series study","volume":"11","author":"Al-Hashimy","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2024.11.005_bib29","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S1473-3099(15)00315-1","article-title":"Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study","volume":"15","author":"Lawes","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajic.2024.11.005_bib30","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3390\/antibiotics11081116","article-title":"Identifying antibiotic use targets for the management of antibiotic resistance using an extended-spectrum beta-lactamase-producing Escherichia coli case: a threshold logistic modeling approach","volume":"11","author":"Aldeyab","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2024.11.005_bib31","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/14787210.2023.2263642","article-title":"Identification of antibiotic consumption targets for the management of Clostridioides difficile infection in hospitals-a threshold logistic modelling approach","volume":"21","author":"Aldeyab","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ajic.2024.11.005_bib32","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/antibiotics11091250","article-title":"A threshold logistic modelling approach for identifying thresholds between antibiotic use and methicillin-resistant Staphylococcus aureus incidence rates in hospitals","volume":"11","author":"Aldeyab","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2024.11.005_bib33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/jac\/dkr116","article-title":"Antibiotic use and the risk of carbapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study","volume":"66","author":"Kritsotakis","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2024.11.005_bib34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jhin.2013.04.018","article-title":"Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?","volume":"84","author":"Goulenok","year":"2013","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2024.11.005_bib35","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","first-page":"106","author":"Clinical and Laboratory Standards Institute","year":"2017"},{"key":"10.1016\/j.ajic.2024.11.005_bib36","unstructured":"World Health Organization. Collaborating centre for drug statistics methodology, guidelines for ATC classification and DDD assignment. Oslo, Norway, 2023. WHO Collaborating Centre for Drug Statistics Methodology; 2024:27."},{"key":"10.1016\/j.ajic.2024.11.005_bib37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.36348\/sjpm.2023.v08i12.002","article-title":"Management of carbapenem-resistant Enterobacteriaceae bloodstream infections: an experience from a tertiary care centre in Oman","volume":"8","author":"Al-Owaisi","year":"2023","journal-title":"Saudi J Pathol Microbiol"},{"key":"10.1016\/j.ajic.2024.11.005_bib38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4269\/ajtmh.21-1242","article-title":"Association between antimicrobial consumption and the prevalence of nosocomial carbapenem-resistant Escherichia coli and Klebsiella pneumoniae in a tertiary hospital in Northern Taiwan","volume":"107","author":"Lee","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ajic.2024.11.005_bib39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/jcpt.12791","article-title":"Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae at a university hospital in Thailand","volume":"44","author":"Prakobsrikul","year":"2019","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ajic.2024.11.005_bib40","article-title":"Impact of antibiotic usage on extended-spectrum beta-lactamase producing Escherichia coli prevalence","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655324008459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655324008459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T17:54:51Z","timestamp":1742234091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655324008459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0196655324008459"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2024.11.005","relation":{},"ISSN":["0196-6553"],"issn-type":[{"type":"print","value":"0196-6553"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Threshold modeling for antibiotic stewardship in Oman","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2024.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and Epidemiology, Inc.","name":"copyright","label":"Copyright"}]}}